Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Xencor Inc Director's Dealing 2017

Feb 1, 2017

32653_dirs_2017-02-01_ab307428-bcac-44d7-b9fc-054801107c14.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Xencor Inc (XNCR)
CIK: 0001326732
Period of Report: 2017-01-30

Reporting Person: Foster Paul A (Chief Medical Officer)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-01-30 Stock Option (right to buy) $22.55 A 85000 Acquired 2027-01-29 Common Stock (85000) Direct

Footnotes

F1: 25% of the shares subject to the option shall vest on the one year anniversary of January 30, 2017 (the "Vesting Commencement Date"), and 1/48th of the shares shall vest monthly thereafter, such that the option shall be fully vested and exercisable on the four year anniversary of the Vesting Commencement Date.